NCT04205565View on ClinicalTrials.gov

Study on Clinical Effectiveness of L-Oxiracetam Injection

PHASE3RecruitingINTERVENTIONAL
Enrollment

591

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

August 30, 2024

Study Completion Date

October 31, 2024

Conditions
Craniocerebral Injury
Interventions
DRUG

Test group: L-oxiracetam Injection

L-oxiracetam injection, 4 vials, once a day, IV. Placebo injection of oxiracetam, 6 vials, once a day, IV.

DRUG

Control group: Oxiracetam Injection

Placebo injection of l-oxiracetam, 4 vials, once a day, IV. Oxiracetam injection, 6 vials, once a day, IV.

DRUG

Placebo group: Placebo Injection

Placebo injection of l-oxiracetam, 4 vials, once a day, IV. Placebo injection of oxiracetam, 6 vials, once a day, IV.

Trial Locations (1)

Unknown

RECRUITING

General Hospital of Tianjin Medical University, Tianjing

All Listed Sponsors
lead

Nanjing Yoko Biomedical Co., Ltd.

INDUSTRY